Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia.
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial / Salvarani, Carlo; Massari, Marco; Costantini, Massimo; Merlo, Domenico Franco; Mariani, Gabriella Lucia; Viale, Pierluigi; Nava, Stefano; Guaraldi, Giovanni; Dolci, Giovanni; Boni, Luca; Savoldi, Luisa; Bruzzi, Paolo; Turrà, Caterina; Catanoso, Mariagrazia; Marata, Anna Maria; Barbieri, Chiara; Valcavi, Annamaria; Franzoni, Francesca; Cavuto, Silvio; Mazzi, Giorgio; Corsini, Romina; Trapani, Fabio; Bartoloni, Alessandro; Barisione, Emanuela; Barbieri, Chiara; Burastero, Giulia Jole; Pan, Angelo; Inojosa, Walter; Scala, Raffaele; Burattini, Cecilia; Luppi, Fabrizio; Codeluppi, Mauro; Tarek, Kamal Eldin; Cenderello, Giovanni; Salio, Mario; Foti, Giuseppe; Dongilli, Roberto; Bajocchi, Gianluigi; Negri, Emanuele Alberto; Ciusa, Giacomo; Fornaro, Giacomo; Bassi, Ilaria; Zammarchi, Lorenzo; Aloè, Teresita; Facciolongo, Nicola. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - ELETTRONICO. - 60:(2022), pp. 1-10. [10.1183/13993003.00025-2022]
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
Boni, Luca;Cavuto, Silvio;Bartoloni, Alessandro;Zammarchi, Lorenzo;
2022
Abstract
Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia.File | Dimensione | Formato | |
---|---|---|---|
2200025.full.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
546.7 kB
Formato
Adobe PDF
|
546.7 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.